|1.||Wood, Paul L: 4 articles (10/2015 - 11/2007)|
|2.||Smith, Tara: 2 articles (06/2015 - 01/2011)|
|3.||Goodenowe, Dayan B: 2 articles (01/2011 - 11/2007)|
|4.||Zoeller, Raphael A: 2 articles (01/2003 - 08/2002)|
|5.||Kaye, Jeffrey A: 1 article (10/2015)|
|6.||Woltjer, Randall L: 1 article (10/2015)|
|7.||Barnette, Brooke L: 1 article (10/2015)|
|8.||Quinn, Joseph F: 1 article (10/2015)|
|9.||Grégoire, Laurent: 1 article (06/2015)|
|10.||Goodenowe, Dayan: 1 article (06/2015)|
|1.||Inborn Genetic Diseases (Disease, Hereditary)
|3.||Alzheimer Disease (Alzheimer's Disease)
01/01/2012 - "There are several reports indicating a decrease of ethanolamine plasmalogen (pl-PE) in brain tissues and in serum of patients with Alzheimer's disease (AD). "
01/01/2011 - "Docosahexaenoic acid (DHA) and DHA-containing ethanolamine plasmalogens (PlsEtn) are decreased in the brain, liver and the circulation in Alzheimer's disease. "
07/01/1999 - "Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease."
04/01/1997 - "Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens."
11/06/1995 - "Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain."
08/01/2002 - "Hypoxia resulted in a selective increase in the turnover of the plasmalogen plasmenylethanolamine. "
01/01/1977 - "Enzymic synthesis of ethanolamine plasmalogens in the microsomal fraction of rat brain under oxygen deficiency."
03/15/1999 - "Restoration of plasmenylethanolamine, which contains the vinyl ether, resulted in wild-type-like resistance to chemical hypoxia and ROS generators, whereas increasing levels of its precursor, which bears the saturated ether, had no effect on cell survival. "
04/01/1995 - "Ten minutes of hypoxia did not cause a significant change in the total phospholipid mass of ethanolamine or choline phospholipids; however, phosphate analysis of the individual phospholipid molecular species containing esterified arachidonic acid in isolated proximal tubules demonstrated a 24% reduction in the mass of the plasmenylethanolamine molecular species with the vinyl ether of oleylaldehyde at the sn-1 position and a 35% reduction in the mass of plasmenylcholine species with palmitaldehyde at the sn-1 position. "
05/01/1994 - "The spectra of type 1 and type 2 tumors were characteristic of degenerative cells that lacked membrane permeability associated with loss of ethanolamine plasmalogen in the presence of significant phospholipid turnover. "
10/22/1990 - "Phospholipase A2 activities with a plasmalogen substrate in brain and in neural tumor cells: a sensitive and specific assay using pyrenesulfonyl-labeled plasmenylethanolamine."
06/27/1994 - "Phospholipids commonly identified in the tumor spectra included phosphatidylglycerol (PG), phosphatidic acid (PA), diphosphatidylglycerol (DPG), uncharacterized phospholipid (U), ethanolamine plasmalogen (EPLAS), phosphatidylethanolamine (PE), phosphatidylserine (PS), sphingomyelin (SM), lysophosphatidylcholine (LPC), phosphatidylinositol (PI), a choline phospholipid (CPLIP), and phosphatidylcholine (PC). "
|9.||Choline (Choline Chloride)
|10.||Phospholipases A2 (Phospholipase A2)